Compare Mesoblast Limited (MESO) vs OneSpan Inc (OSPN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs OneSpan Inc — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while OneSpan Inc trades at $16.25 (market cap $600.69M). The key difference: Mesoblast Limited is far larger — about 3.7× OneSpan Inc's market cap, and OneSpan Inc pays a 3.19% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | OSPN | |
|---|---|---|
Market Cap | $2.21B | $600.69M |
Sector | Technology | Technology |
52-Week High | $20.96 | $16.78 |
52-Week Low | $12.88 | $10.15 |
Enterprise Value | $2.21B | $569.77M |
Dividend Yield | — | 3.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About OneSpan Inc
OneSpan Inc. is a global leader in providing digital agreement security solutions. The company's platform helps organizations, primarily in the financial services sector, to secure their digital agreements and transactions, including e-signatures, multi-factor authentication, and transaction monitoring. OneSpan's technology is focused on protecting customers from fraud and meeting regulatory compliance requirements in a digital-first environment.
Read more on OSPN →
